We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSI icon
326
Motorola Solutions
MSI
$70.6B
$3.89M 0.06%
33,798
+4,240
+14% +$526K
WDC icon
327
Western Digital
WDC
$169B
$3.84M 0.06%
137,584
+89,273
+185% +$3.16M
MAR icon
328
Marriott International
MAR
$100B
$3.84M 0.06%
35,338
+3,195
+10% +$367K
SRE icon
329
Sempra
SRE
$60.1B
$3.83M 0.06%
70,904
+30,892
+77% +$1.76M
BHBK
330
DELISTED
Blue Hills Bancorp, Inc.
BHBK
$3.79M 0.06%
177,663
+33,691
+23% +$775K
MAS icon
331
Masco
MAS
$16.2B
$3.79M 0.06%
129,535
+8,999
+7% +$280K
SYY icon
332
Sysco
SYY
$40B
$3.77M 0.06%
60,135
+2,703
+5% +$182K
BSX icon
333
Boston Scientific
BSX
$68.5B
$3.75M 0.06%
106,194
-2,791
-3% -$101K
LJPC
334
DELISTED
La Jolla Pharmaceutical Company
LJPC
$3.7M 0.06%
392,300
– –
PXD
335
DELISTED
Pioneer Natural Resource Co.
PXD
$3.67M 0.06%
27,878
+5,085
+22% +$777K
QRVO icon
336
Qorvo
QRVO
$7.8B
$3.64M 0.06%
59,990
-101,719
-63% -$6.84M
VECO icon
337
Veeco
VECO
$2.87B
$3.62M 0.06%
489,002
-126,441
-21% -$1.08M
JNPR
338
DELISTED
Juniper Networks
JNPR
$3.62M 0.06%
134,491
+15,868
+13% +$449K
EW icon
339
Edwards Lifesciences
EW
$48B
$3.62M 0.06%
70,809
-3,009
-4% -$152K
NATI
340
DELISTED
National Instruments Corp
NATI
$3.61M 0.06%
79,501
+2,350
+3% +$110K
CDNS icon
341
Cadence Design Systems
CDNS
$93.8B
$3.6M 0.06%
+82,699
New +$3.59M
BLK icon
342
Blackrock
BLK
$163B
$3.55M 0.05%
9,048
-8
-0.1% -$3.28K
MDGL icon
343
Madrigal Pharmaceuticals
MDGL
$12.8B
$3.54M 0.05%
31,450
+17,500
+125% +$2.71M
FDX icon
344
FedEx
FDX
$73.7B
$3.53M 0.05%
21,886
+912
+4% +$193K
HPE icon
345
Hewlett Packard
HPE
$62.5B
$3.53M 0.05%
266,902
-247,391
-48% -$3.71M
PVH icon
346
PVH
PVH
$3.83B
$3.49M 0.05%
37,528
+31,837
+559% +$3.64M
ECL icon
347
Ecolab
ECL
$76.3B
$3.47M 0.05%
23,558
+18,994
+416% +$2.9M
BALL icon
348
Ball Corp
BALL
$17.2B
$3.46M 0.05%
75,241
-51,620
-41% -$2.41M
HAL icon
349
Halliburton
HAL
$27.3B
$3.43M 0.05%
129,029
+3,707
+3% +$125K
CCI icon
350
Crown Castle
CCI
$32.8B
$3.38M 0.05%
31,138
+2,030
+7% +$223K
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.